Xiao Tan
  • Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges University, China
  • Microbiology


Ph.D, UPMC, Paris, France, 2013

Current position

Lecture in Biochemistry, College of Medical Science, China Three Gorges University, China


  1. Tan, X., Soualmia, F., Furio, L., Renard, J. F., Kempen, I., Qin, L., Pagano, M., Pirotte, B., El Amri, C., Hovnanian, A. and Reboud-Ravaux, M. (2015). Toward the first class of suicide inhibitors of kallikreins involved in skin diseases. J Med Chem 58(2): 598-612.
  2. Tan, X., Furio, L., Reboud-Ravaux, M., Villoutreix, B. O., Hovnanian, A. and El Amri, C. (2013). 1,2,4-Triazole derivatives as transient inactivators of kallikreins involved in skin diseases. Bioorg Med Chem Lett 23(16): 4547-4551.
  3. Tan, X., Bertonati, C., Qin, L., Furio, L., El Amri, C., Hovnanian, A., Reboud-Ravaux, M. and Villoutreix, B. O. (2013). Identification by in silico and in vitro screenings of small organic molecules acting as reversible inhibitors of kallikreins. Eur J Med Chem 70: 661-668.
  4. Liao, C., Wang, Y., Tan, X., Sun, L. and Liu, S. (2015). Discovery of novel inhibitors of human S-adenosylmethionine decarboxylase based on in silico high-throughput screening and a non-radioactive enzymatic assay. Sci Rep 5: 10754.